Diabetes Clinical Trials in Tennessee

Showing 401-420 of 611 trials

The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care

NCT01344668

The primary hypotheses are that the intervention will improve A1C, blood pressure, lipids, weight, self-efficacy, self-management behaviors, and use of clinical services at 12 and 24 months follow-up.

Type 2 Diabetes

Vanderbilt University411 participantsStarted May 2011

Nashville, Tennessee, United States

COMPLETEDPhase 342 miles

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

NCT00859898

The primary purpose of this study is to compare the change from baseline in hemoglobin A1C achieved with dapagliflozin 10 mg in combination with metformin XR as compared with metformin XR monotherapy and compared with Dapagliflozin monotherapy, after 24 weeks of oral administration of double-blind treatment. The safety of treatment with dapagliflozin will also be assessed in this study

Type 2 Diabetes Mellitus

AstraZeneca1,093 participantsStarted Apr 2009

Ozark, Alabama, United States • Tempe, Arizona, United States • Tempe, Arizona, United States +120 more locations

The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

Diabetes Trials in Other Cities

Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

Southeastern Diabetes Initiative Clinical Intervention

Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

Other Conditions in Tennessee